SCHEMBL8559825

SCHEMBL8559825

[CH2]C(Cl)c1cccs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1258559 0.79
SCHEMBL5063737 0.79 CES2 (0.47)
SCHEMBL9563280 0.79 CES2 (0.42)
SCHEMBL10465316 0.75
SCHEMBL6897415 0.75
SCHEMBL4169741 0.75
SCHEMBL6385380 0.75
SCHEMBL94536 0.75
SCHEMBL1309424 0.75
SCHEMBL15206829 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0837855-A4 METHOD FOR PREPARING N-MONOSUBSTITUTED AND N,N'-DISUBSTITUTED UNSYMMETRICAL CYCLIC UREAS DU PONT MERCK PHARMA (US) 1998-09-02 EP claimed
EP-0837855-A1 METHOD FOR PREPARING N-MONOSUBSTITUTED AND N,N'-DISUBSTITUTED UNSYMMETRICAL CYCLIC UREAS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1998-04-29 EP claimed
WO-1996040652-A1 METHOD FOR PREPARING N-MONOSUBSTITUTED AND N,N'-DISUBSTITUTED UNSYMMETRICAL CYCLIC UREAS THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1996-12-19 WO claimed
EP-3261443-B1 DESACETOXYTUBULYSIN H AND ANALOGS THEREOF UNIV RICE WILLIAM M (US) 2021-04-28 EP disclosed
US-10899773-B2 Total synthesis of trioxacarcin DC-45-A2 and preparation of trioxacarcin analogs WILLIAM MARSH RICE UNIVERSITY (US) 2021-01-26 US disclosed
US-10808007-B2 Desacetoxytubulysin H and analogs thereof WILLIAM MARSH RICE UNIVERSITY (US) 2020-10-20 US disclosed
US-10456400-B2 Aza-ellipticine analogs, methods of synthesis and methods of treatment MUSC FOUNDATION FOR RESEARCH DEVELOPMENT (US) 2019-10-29 US disclosed
US-10370327-B2 Ionic liquid films with multiple functionalities for surface modification of biomedical alloys BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2019-08-06 US disclosed
US-20190023717-A1 TOTAL SYNTHESIS OF TRIOXACARCIN DC-45-A2 AND PREPARATION OF TRIOXACARCIN ANALOGS WILLIAM MARSH RICE UNIVERSITY (US) 2019-01-24 US disclosed
WO-2017180248-A9 ENANTIOENRICHED VIRIDICATUMTOXIN B ANALOGS WILLIAM MARSH RICE UNIVERSITY (US) 2018-11-01 WO disclosed
US-10065924-B2 Preparation and biological evaluation of viridicatumtoxin analogs WILLIAM MARSH RICE UNIVERSITY (US) 2018-09-04 US disclosed
WO-2017100514-A1 LIPOPHILIC ANALOGS OF CJ-16264, METHODS OF USE, AND SYNTHESIS THEREOF WILLIAM MARSH RICE UNIVERSITY (US) 2017-06-15 WO disclosed
US-20170137380-A1 IONIC LIQUID FILMS WITH MULTIPLE FUNCTIONALITIES FOR SURFACE MODIFICATION OF BIOMEDICAL ALLOYS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2017-05-18 US disclosed
EP-3145507-A1 AZA-ELLIPTICINE ANALOGS, METHODS OF SYNTHESIS AND METHODS OF TREATMENT Musc Foundation for Research Development (US) 2017-03-29 EP disclosed
US-20170081328-A1 AZA-ELLIPTICINE ANALOGS, METHODS OF SYNTHESIS AND METHODS OF TREATMENT MEDICAL UNIVERSITY OF SOUTH CAROLINA 2017-03-23 US disclosed
WO-2016138288-A1 DESACETOXYTUBULYSIN H AND ANALOGS THEREOF WILLIAM MARSH RICE UNIVERSITY (US) 2016-09-01 WO disclosed
WO-2016100833-A2 TOTAL SYNTHESIS OF TRIOXACARCIN DC-45-A2 AND PREPARATION OF TRIOXACARCIN ANALOGS WILLIAM MARSH RICE UNIVERSITY (US) 2016-06-23 WO disclosed
WO-2016014643-A1 PREPARATION AND BIOLOGICAL EVALUATION OF VIRIDICATUMTOXIN ANALOGS WILLIAM MARSH RICE UNIVERSITY (US) 2016-01-28 WO disclosed
WO-2016004366-A1 IONIC LIQUID FILMS WITH MULTIPLE FUNCTIONALITIES FOR SURFACE MODIFICATION OF BIOMEDICAL ALLOYS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2016-01-07 WO disclosed
WO-2015179218-A1 AZA-ELLIPTICINE ANALOGS, METHODS OF SYNTHESIS AND METHODS OF TREATMENT MUSC FOUNDATION FOR RESEARCH DEVELOPMENT (US) 2015-11-26 WO disclosed